UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 19, 2016
BIOAMBER INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Delaware |
|
001-35905 |
|
98-0601045 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
1250 Rene Levesque West, Suite 4310 Montreal, Quebec, Canada H3B 4W8 |
|
3850 Lane North, Suite 180 Plymouth, Minnesota 55447 |
|
(Address of principal executive offices) |
||
Registrant’s telephone number, including area code (514) 844-8000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders.
BioAmber Inc. (the “Company”) held its Annual Meeting of Shareholders on May 19, 2016 in New York, New York (the “Annual Meeting”). According to the inspector of elections, the stockholders present in person or by proxy represented 19,742,596 shares of common stock (entitled to one vote per share). The number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes with respect to each proposal voted upon at the Annual Meeting are set forth below.
Proposal 1 – The Election of Class III Directors. The stockholders voted on the election of three Class III directors, Jean-François Huc, Raymond J. Land and Kenneth W. Wall, to hold office until the 2019 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal. The stockholders voted as follows:
|
|
|
|
|
|
|
|
|
|
|
Votes For |
|
Votes Withheld |
|
Abstentions |
|
Broker Non-Votes |
|
|
|
|
|
|
|
|
|
|
Jean-Francois Huc |
13,243,461 |
|
54,774 |
|
_ |
|
6,444,361 |
|
Raymond J. Land |
11,918,850 |
|
1,379,385 |
|
_ |
|
6,444,361 |
|
Kenneth W. Wall |
13,243,672 |
|
54,563 |
|
_ |
|
6,444,361 |
Accordingly, Messrs. Huc, Land and Wall were elected to the Company’s board of directors.
Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders voted on the ratification of the appointment of Deloitte LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2016. The stockholders voted as follows:
|
|
|
|
|
|
|
Votes For |
|
Votes Against |
|
Abstentions |
|
|
|
|
|
|
|
19,606,637 |
|
133,022 |
|
2,937 |
Accordingly, the appointment of independent registered public accounting firm was ratified.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
Date: May 20, 2016 |
|
|
|
BIOAMBER INC. |
||
|
|
|
|
|
|||
|
|
|
|
|
By: |
|
/s/ Jean-François Huc |
|
|
|
|
|
|
|
Jean-François Huc |
|
|
|
|
|
|
|
President, Chief Executive Officer and Director |